--- title: 'Principal Associate II, Quality Assurance Operations at Replimune' canonical: 'https://feeny.ai/job/principal-associate-ii-quality-assurance-operations-replimune-framingham-0ahe7z9s4q5e' type: 'job' last_seen: '2026-09-09' --- # Principal Associate II, Quality Assurance Operations at Replimune - **Company:** Replimune - **Location:** Framingham, MA - **Employment:** full-time - **Work type:** onsite - **Posted:** 2026-07-20 - **Last confirmed live:** 2026-09-09 - **Apply:** https://jobs.ashbyhq.com/replimune/dc8af1e5-c677-4a20-be47-a4cbba4f8204 ## Job description ## Overview Replimune’s mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response, boldly transforming cancer care because patient’s lives depend on it. At Replimune, we live by our values: United: We Collaborate for a Common Goal. Audacious: We Are Bold. Dedicated: We Give Our Full Commitment. Candid: We Are Honest With Each Other. People are at the center of everything we do, and when it comes to our employees, we make it personal. With a deep sense of purpose, a strong and evolving culture, a competitive and forward-looking total rewards program, everyone at Replimune has a unique opportunity to impact on the lives of patients, caregivers and themselves. Join us, as we reshape the future. 2 - This position is based in our Framingham location and typically has a 5-day on-site expectation. Key responsibilities: - Work cross functionally with Quality Assurance, Quality Control, Regulatory and Clinical groups to ensure inspection readiness. - Manage/coordinate internal and external batch release for GMP lots, through batch disposition and subsequent release and issuance of Certificate of Analysis / Conformance. - Manage Product Complaints for Commercial Product - Responsible for verifying all batches manufactured are compliant with Good Manufacturing Practices 21 CFR 210 and 211, product registration, marketing authorization and all other applicable requirements through review of testing records, investigations, non-conformances and out-of-specifications as part of the batch release process. - Reviewing packaging master batch records, packaging, labeling for investigational medicinal product. - Responsible for final approval and authorization of finished product for shipment and subsequent approval of packaging events. - Notifies Management of potential quality or regulatory issues that may affect product quality or regulatory compliance, including a summary of findings for any batch that does not meet the standard requirements for final disposition. - Drive improvement of Replimune GMP compliance and Quality systems: change control, deviation, and corrective and preventive action (CAPA) systems including support of thorough root cause analysis investigations related to quality issues. - Oversee progression of batch related Out of Specification investigations and deviations to ensure timely progression for release. - Collect and provide input to and communicate performance metrics and data trends to Management for Batch Release related activities. - Lead, mentor and coach quality assurance personnel through development of training to support batch release activities/processes. - Support internal/external batch release audits as Subject Matter Expert. Other responsibilities - As assigned Educational requirements: - Bachelor degree in appropriate Science (chemistry, biology, biochemistry, microbiology) required; MSc or PhD preferred Experience and skill requirement: - Minimum 6+ years of experience in GCP, GMP, and Quality Assurance/Compliance in the pharmaceutical, biopharma/biologics industry performing direct hands-on work in Quality - Assurance, Quality Control, laboratories, manufacturing, supply chain, facilities, or engineering. - A working knowledge of GxP practices, US FDA and EU GMP regulations and ICH guidelines. - Demonstrated knowledge and direct experience with Quality Systems and GxP compliance within a regulated environment. - Experience managing product complaints is preferred. - Experience managing quality events (i.e. Deviations, CAPA). - Experience with Master Control, Veeva or eQMS systems preferred. - Excel, PowerPoint, Word, SmartSheets proficient - Experience revising procedures and documents. - Excellent attention to detail. - Excellent verbal and written communication and presentation skills across all levels. - Prioritize and manage multiple priorities and projects with little assistance. - Familiarity with clinical and commercial supply areas and processes Salary Range Replimune is committed to fair and equitable compensation practices, and we strive to provide employees with total compensation packages that are market competitive. For this role, the anticipated base pay range is $134,000 $173,500 The exact base pay offered for this role will depend on various factors, including but not limited to the selected candidate’s unique set of qualifications, skills, and experience. Our current organizational needs also play a part in determining your final offer. At Replimune, base pay is only one part of your total compensation package. The selected candidate will be eligible for an annual performance incentive bonus, new hire equity, and ongoing performance-based equity. Replimune also offers various benefits offerings, including, but not limited to, medical, dental, and vision insurance, 401k match, flexible time off, and a number of paid holidays including year-end shutdown. ## About Replimune Replimune Group, Inc., headquartered in Woburn, MA, was founded in 2015 with the mission to transform cancer treatment by pioneering the development of a novel portfolio of oncolytic immunotherapies. Replimune’s proprietary RPx platform is based on a potent HSV-1 backbone intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The RPx platform is designed to have a unique dual local and systemic activity consisting of direct selective virus-mediated killing of the tumor resulting in the release of tumor derived antigens and altering of the tumor microenvironment to ignite a strong and durable systemic response. The RPx product candidates are expected to be synergistic with most established and experimental cancer treatment modalities, leading to the versatility to be developed alone or combined with a variety of other treatment options. For more information, please visit www.replimune.com http://www.replimune.com. We are an Equal Opportunity Employer. ## About Replimune ## Company Overview - **One-liner**: Replimune is a clinical-stage biotech company focused on revolutionizing cancer treatment with a new class of oncolytic immunotherapies intended to activate a powerful and durable full-body anti-tumor response. - **Entity Type**: Public (ticker not explicitly provided in search results, but company is publicly traded) - **Headquarters**: Framingham, Massachusetts, USA (with additional locations in Woburn, MA and Oxfordshire, UK) - **Founded**: 2015 - **Founders**: Robert Coffin, Ph.D. (Founder and Chief Scientist) ## Core Business - **Primary industry**: Biotechnology – oncology, oncolytic immunotherapy - **Target customers**: B2B (pharmaceutical partners) and ultimately patients through healthcare providers - **Mission**: To ignite a systemic immune response to cancer and reshape the future of cancer care ## Products & Services - **RPx Platform**: Proprietary, next-generation HSV-1-based oncolytic immunotherapy platform that powers all pipeline candidates. - **RP1**: Investigational oncolytic immunotherapy for advanced melanoma (IGNYTE trial, PDUFA date April 10, 2026) and non-melanoma skin cancers; also being studied as monotherapy in organ transplant patients with skin cancer (ARTACUS trial). - **RP2**: Investigational oncolytic immunotherapy for metastatic uveal melanoma (Phase 2/3 RP2-202 trial) and hepatocellular carcinoma (Phase 2 in combination with atezolizumab/bevacizumab). ## Market Standing - **Valuation/Market Cap**: Not publicly available in provided sources - **Key Metric**: Clinical-stage; no approved products yet. Key regulatory milestone: FDA action date for RP1 in advanced melanoma on April 10, 2026. - **Notable Partners**: Bristol-Myers Squibb (supply of nivolumab), Roche (supply of atezolizumab and bevacizumab) – Replimune retains full commercial rights. - **Growth Signals**: Completed enrollment in IGNYTE trial; confirmatory IGNYTE-3 trial underway; own 63,000 sq ft U.S. manufacturing facility in Woburn, MA enabling global commercial supply; broad pipeline across multiple solid tumor indications. ## Competitive Advantages - **Strong IP position**: Wholly-owned, unencumbered RPx platform with broad patent protection. - **In-house manufacturing**: Dedicated U.S. facility for commercial-scale production, reducing reliance on contract manufacturers. - **First-mover potential**: Poised to be one of the first oncolytic immunotherapies to reach the market if RP1 gains FDA approval. - **Full rights retained**: All partnership agreements allow Replimune to keep full commercial rights to its therapies. ## Strategic Focus - Advancing RP1 toward FDA approval in advanced melanoma (April 2026 PDUFA date) - Expanding pipeline into additional indications (uveal melanoma, hepatocellular carcinoma, non-melanoma skin cancers) - Building out commercial infrastructure and manufacturing capabilities - Exploring combination therapies with checkpoint inhibitors (nivolumab, atezolizumab) ## Why Work Here - **Culture**: Cross-functional, collaborative, values-driven environment. Employee survey results show 92% proud to work at Replimune, 88% feel they make a positive difference, 78% would recommend the company. - **Flexibility**: Hybrid and remote work options available depending on role; home office and mobile phone stipend provided. - **Compensation**: New hire equity grants, generous annual bonus plans, retirement plans with substantial company match (100% vested from day one). - **Benefits**: Medical, dental, and vision insurance 100% paid by the company. - **Locations**: U.S. (Woburn, MA and Framingham, MA) and UK (Oxfordshire) – opportunities to work across both sites. ## Sources 1. [Replimune Homepage](https://www.replimune.com/) 2. [Replimune Careers](https://www.replimune.com/careers) 3. [Replimune About Us](https://www.replimune.com/about-us) 4. [Replimune Team](https://www.replimune.com/team) 5. [Replimune Pipeline](https://www.replimune.com/pipeline) ## Other roles at Replimune - [Director, HR Business Partner](https://feeny.ai/job/director-hr-business-partner-replimune-milton-park-z5a3s7k1jy7g) — Milton Park - [Executive Director, Market Access and Value](https://feeny.ai/job/executive-director-market-access-and-value-replimune-woburn-nf352x5v48bh) — Woburn, MA - [Scientist II, Quality Control](https://feeny.ai/job/scientist-ii-quality-control-replimune-framingham-sf1y1pmqxbjw) — Framingham, MA - [Senior Manager, Data Management](https://feeny.ai/job/senior-manager-data-management-replimune-woburn-kesxh7s9ktmd) — Woburn, MA - [Operational Excellence Lead I (PharmD)](https://feeny.ai/job/operational-excellence-lead-i-pharmd-replimune-woburn-xt9zv5h9hb19) — Woburn, MA - [Senior Strategic Account Manager - Omaha](https://feeny.ai/job/senior-strategic-account-manager-omaha-replimune-woburn-zd29jhn75tz0) — Woburn, MA - [Manufacturing Associate I](https://feeny.ai/job/manufacturing-associate-i-replimune-framingham-a9c083cyq8ms) — Framingham, MA - [Manufacturing Technician](https://feeny.ai/job/manufacturing-technician-replimune-framingham-b4s89qjyc580) — Framingham, MA - [Sr. Scientist, Process Development & Technology](https://feeny.ai/job/sr-scientist-process-development-technology-replimune-framingham-h5fn33dyrqr9) — Framingham, MA - [Manager, Regulatory Operations (Publishing)](https://feeny.ai/job/manager-regulatory-operations-publishing-replimune-woburn-pjc393jvsvg4) — Woburn, MA